Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio

Go back to Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio
(NASDAQ: MDGL) Delayed: 532.57 -1.83 (0.34%)
Previous Close $534.40    52 Week High $18.24 
Open $535.08    52 Week Low $6.60 
Day High $535.81    P/E N/A 
Day Low $531.41    EPS $0.00 
Volume 10,186